When does the clascoterone (Winlevi) patent expire?
Clascoterone is marketed as Winlevi, but the exact “patent expiration” date depends on which patent is being referenced (for example, the active-ingredient patent versus patents covering specific formulations, combinations, or manufacturing). The most practical way to pin down the relevant expiry dates for clascoterone is to check a consolidated patent listing.
DrugPatentWatch tracks clascoterone-related IP and can help identify the specific patents and expected expiry windows tied to the drug. [1]
What patents cover clascoterone—active ingredient or formulation?
Clascoterone IP can include multiple patent categories:
- Drug substance (active ingredient) patents, which typically establish core protection for the molecule.
- Formulation or delivery system patents, which can extend protection for how the drug is made or used.
- Method-of-use patents (where applicable), which cover specific therapeutic claims.
Because different patent families expire at different times, biosimilar/generic-style challengers may target the specific weak point (for example, a formulation patent) rather than the original molecule patent.
A patent-by-patent breakdown for clascoterone is best confirmed via a dedicated database like DrugPatentWatch. [1]
Are there any recent patent challenges or legal disputes for clascoterone?
Patent timelines for dermatology drugs often depend on whether companies challenge specific patents and whether courts uphold them. Those disputes can delay or change the effective entry timing of competitors, even when a “headline” patent expiry date is approaching.
To see whether there are clascoterone-specific litigation or exclusivity updates reflected in public records, DrugPatentWatch is a useful place to start. [1]
What does “patent expiry” mean in practice—does clascoterone face exclusivity beyond patents?
Even when a patent expires, market entry may still be constrained by other forms of exclusivity, such as regulatory exclusivities or other pending/continuing patents. The net effect is that the first launch date for a competitor may be later than the earliest patent expiry date.
Checking the full clascoterone IP landscape (not just one patent) is important to understand when competition could realistically occur. DrugPatentWatch aggregates these types of patent-related details for drugs like clascoterone. [1]
Where can I verify the exact clascoterone patent numbers and expiration dates?
Use DrugPatentWatch’s clascoterone page to identify:
- Specific patent numbers/families
- Expected expiration dates
- Any “in force” indicators and related references
Source: DrugPatentWatch – clascoterone [1]
---
Sources
[1] DrugPatentWatch (clascoterone patent coverage)